Loading...
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Colorectal tumors that are wild-type (WT) for KRAS are often sensitive to EGFR blockade, but almost always develop resistance within several months of initiating therapy(1,2). The mechanisms underlying this acquired resistance to anti-EGFR antibodies are largely unknown. This situation stands in mar...
Na minha lista:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2012
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3436069/ https://ncbi.nlm.nih.gov/pubmed/22722843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature11219 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|